Genoplan provides the genetic-code-based solution which helps people manage their weight. The solution analyzes user’s unique genetic characteristics and provides personalized weight management solution according to the test result. Since Genoplanuses saliva to analyze genetic characteristics, its process is more simple, quicker and cheaper than existing solutions in the market. Genoplanalso guarantees high accuracy by using equipment from Roche Diagnostics, one of the world's top medical device makers in this space.

Status:  Current

Sector(s):  Healthcare

Geography:  Seoul, Korea

Other Investors:  SparkLabs Accelerator, Samsung Ventures, Softbank Ventures

Website:  http://www.genoplan.com/